Free Trial

AMETEK (AME) Financials

AMETEK logo
$241.27 +6.73 (+2.87%)
As of 12:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for AMETEK

Annual Income Statements for AMETEK

This table shows AMETEK's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
591 512 681 778 861 872 990 1,160 1,313 1,376 1,480
Consolidated Net Income / (Loss)
591 512 681 778 861 872 990 1,160 1,313 1,376 1,480
Net Income / (Loss) Continuing Operations
591 512 681 778 861 872 990 1,160 1,313 1,376 1,480
Total Pre-Tax Income
806 693 797 988 1,070 1,082 1,223 1,429 1,606 1,662 1,798
Total Operating Income
908 791 904 1,076 1,177 1,028 1,309 1,501 1,707 1,780 1,910
Total Gross Profit
1,356 1,255 1,439 1,660 1,788 1,544 1,913 2,145 2,384 2,476 2,667
Total Revenue
3,974 3,840 4,300 4,846 5,159 4,540 5,547 6,151 6,597 6,941 7,401
Operating Revenue
3,974 3,840 4,300 4,846 5,159 4,540 5,547 6,151 6,597 6,941 7,401
Total Cost of Revenue
2,618 2,585 2,861 3,186 3,371 2,997 3,634 4,005 4,212 4,465 4,734
Operating Cost of Revenue
2,618 2,585 2,861 3,186 3,371 2,997 3,634 4,005 4,212 4,465 4,734
Total Operating Expenses
449 464 535 584 610 516 604 645 677 697 757
Selling, General & Admin Expense
449 464 535 584 610 516 604 645 677 697 757
Total Other Income / (Expense), net
-101 -98 -107 -88 -108 54 -86 -72 -101 -118 -112
Interest Expense
92 94 98 82 88 86 80 83 82 113 81
Other Income / (Expense), net
-9.54 -3.57 -8.86 -5.62 -19 140 -5.12 11 -19 -5.06 -31
Income Tax Expense
216 181 115 210 208 210 233 269 293 285 318
Basic Earnings per Share
$2.46 $2.20 $2.96 $3.37 $3.78 $3.80 $4.29 $5.04 $5.70 $5.95 $6.42
Weighted Average Basic Shares Outstanding
239.91M 232.59M 230.23M 230.82M 227.76M 229.44M 230.96M 230.21M 230.52M 231.26M 230.45M
Diluted Earnings per Share
$2.45 $2.19 $2.94 $3.34 $3.75 $3.77 $4.25 $5.01 $5.67 $5.93 $6.40
Weighted Average Diluted Shares Outstanding
241.59M 233.73M 231.85M 232.71M 229.40M 231.15M 232.81M 231.54M 231.51M 232.17M 231.26M
Weighted Average Basic & Diluted Shares Outstanding
240.20M 232.80M 230.20M 230.80M 229.12M 230.56M 231.70M 230.09M 231.01M 230.66M 228.98M

Quarterly Income Statements for AMETEK

This table shows AMETEK's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
340 343 311 338 340 387 352 358 371 399 399
Consolidated Net Income / (Loss)
340 343 311 338 340 387 352 358 371 399 399
Net Income / (Loss) Continuing Operations
340 343 311 338 340 387 352 358 371 399 399
Total Pre-Tax Income
413 417 381 417 419 444 434 442 448 474 493
Total Operating Income
438 445 417 448 446 469 455 462 488 505 515
Total Gross Profit
602 615 591 624 616 645 625 636 686 720 718
Total Revenue
1,623 1,731 1,736 1,735 1,709 1,762 1,732 1,778 1,893 1,998 1,928
Operating Revenue
1,623 1,731 1,736 1,735 1,709 1,762 1,732 1,778 1,893 1,998 1,928
Total Cost of Revenue
1,021 1,116 1,145 1,110 1,093 1,117 1,107 1,142 1,207 1,278 1,211
Operating Cost of Revenue
1,021 1,116 1,145 1,110 1,093 1,117 1,107 1,142 1,207 1,278 1,211
Total Operating Expenses
164 170 174 177 170 176 170 174 198 215 203
Selling, General & Admin Expense
164 170 174 177 170 176 170 174 198 215 203
Total Other Income / (Expense), net
-25 -28 -36 -31 -27 -25 -21 -19 -40 -31 -22
Interest Expense
18 24 35 31 25 22 19 17 23 23 21
Other Income / (Expense), net
-6.26 -3.94 -0.63 0.09 -1.89 -2.63 -1.61 -2.60 -18 -8.61 -1.05
Income Tax Expense
73 74 70 79 79 57 82 84 77 75 94
Basic Earnings per Share
$1.48 $1.48 $1.35 $1.46 $1.47 $1.67 $1.52 $1.55 $1.61 $1.74 $1.74
Weighted Average Basic Shares Outstanding
230.69M 230.52M 231.10M 231.44M 231.34M 231.26M 230.67M 230.82M 230.73M 230.45M 228.90M
Diluted Earnings per Share
$1.47 $1.48 $1.34 $1.45 $1.47 $1.67 $1.52 $1.55 $1.60 $1.73 $1.74
Weighted Average Diluted Shares Outstanding
231.75M 231.51M 232.04M 232.30M 232.22M 232.17M 231.54M 231.47M 231.67M 231.26M 229.84M
Weighted Average Basic & Diluted Shares Outstanding
230.80M 231.01M 231.47M 231.54M 231.31M 230.66M 230.88M 230.95M 230.20M 228.98M 229.20M
Cash Dividends to Common per Share
$0.25 - $0.28 $0.28 $0.28 - $0.31 $0.31 $0.31 - $0.34

Annual Cash Flow Statements for AMETEK

This table details how cash moves in and out of AMETEK's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
3.39 336 -71 -292 39 820 -866 -1.39 64 -36 84
Net Cash From Operating Activities
673 757 833 926 1,114 1,281 1,160 1,149 1,735 1,829 1,802
Net Cash From Continuing Operating Activities
673 757 833 926 1,114 1,281 1,160 1,149 1,735 1,829 1,802
Net Income / (Loss) Continuing Operations
591 512 681 778 861 872 990 1,160 1,313 1,376 1,480
Consolidated Net Income / (Loss)
591 512 681 778 861 872 990 1,160 1,313 1,376 1,480
Depreciation Expense
149 180 183 199 234 255 292 319 338 383 423
Non-Cash Adjustments To Reconcile Net Income
20 26 18 20 50 -107 44 14 42 25 39
Changes in Operating Assets and Liabilities, net
-88 39 -49 -72 -31 261 -165 -343 42 45 -140
Net Cash From Investing Activities
-426 -452 -626 -1,210 -1,151 62 -2,056 -553 -2,376 -245 -1,063
Net Cash From Continuing Investing Activities
-426 -452 -626 -1,210 -1,151 62 -2,056 -553 -2,376 -245 -1,063
Purchase of Property, Plant & Equipment
-69 -63 -75 -82 -102 -74 -111 -139 -136 -127 -130
Acquisitions
-356 -391 -557 -1,129 -1,062 -117 -1,959 -430 -2,238 -118 -933
Other Investing Activities, net
-0.01 2.33 5.89 1.34 13 7.03 2.05 12 -2.27 -0.22 0.72
Net Cash From Financing Activities
-217 57 -329 13 73 -539 39 -576 697 -1,602 -686
Net Cash From Continuing Financing Activities
-217 57 -329 13 73 -539 39 -576 697 -1,602 -686
Repayment of Debt
45 -367 -280 -313 25 -435 -65 -17 -7.75 -309 -525
Repurchase of Common Equity
-435 -336 -6.87 -368 -12 -4.69 -15 -333 -7.77 -212 -434
Payment of Dividends
-86 -83 -83 -129 -127 -165 -185 -202 -230 -259 -285
Issuance of Debt
200 821 - 818 100 - 244 -74 892 -890 521
Other Financing Activities, net
60 23 40 4.52 87 65 60 50 51 67 36
Other Net Changes in Cash
- - - - - - -10 -22 8.27 -17 31

Quarterly Cash Flow Statements for AMETEK

This table details how cash moves in and out of AMETEK's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
236 -432 -36 23 -0.31 -22 25 221 -180 19 23
Net Cash From Operating Activities
473 541 410 381 487 550 418 359 441 584 452
Net Cash From Continuing Operating Activities
473 541 410 381 487 550 418 359 441 584 452
Net Income / (Loss) Continuing Operations
340 343 311 338 340 387 352 358 371 399 399
Consolidated Net Income / (Loss)
340 343 311 338 340 387 352 358 371 399 399
Depreciation Expense
82 92 98 99 90 96 106 108 103 106 105
Non-Cash Adjustments To Reconcile Net Income
2.24 19 4.90 7.47 3.28 9.12 4.41 11 13 10 -16
Changes in Operating Assets and Liabilities, net
48 86 -3.62 -62 53 58 -45 -118 -46 70 -37
Net Cash From Investing Activities
-176 -2,050 -21 -22 -26 -175 -126 -30 -850 -57 -235
Net Cash From Continuing Investing Activities
-176 -2,050 -21 -22 -26 -175 -126 -30 -850 -57 -235
Purchase of Property, Plant & Equipment
-29 -60 -28 -21 -26 -52 -23 -29 -21 -57 -25
Acquisitions
-147 -1,991 0.00 - - -118 -103 -0.95 -829 - -210
Other Investing Activities, net
-0.26 0.88 6.24 -1.38 0.96 -6.05 0.52 0.20 - -0.00 0.47
Net Cash From Financing Activities
-48 1,062 -418 -334 -477 -374 -278 -132 233 -510 -188
Net Cash From Continuing Financing Activities
-48 1,062 -418 -334 -477 -374 -278 -132 233 -510 -188
Repayment of Debt
-0.13 -2.68 -6.53 -2.03 -299 -0.80 -7.80 -50 -190 -277 -9.19
Repurchase of Common Equity
-0.05 -1.19 -6.92 -0.68 -60 -144 -18 -0.11 -146 -270 -28
Payment of Dividends
-58 -58 -65 -65 -65 -65 -71 -72 -71 -71 -78
Issuance of Debt
-0.95 1,113 -363 -278 -57 -192 -185 -18 630 94 -83
Other Financing Activities, net
11 11 24 11 5.20 27 4.67 7.67 9.26 15 9.64
Other Net Changes in Cash
-13 15 -7.31 -2.39 15 -23 11 23 -4.04 1.10 -5.70

Annual Balance Sheets for AMETEK

This table presents AMETEK's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
6,660 7,101 7,796 8,662 9,845 10,357 11,898 12,431 15,024 14,631 16,068
Total Current Assets
1,619 1,928 1,935 1,836 2,026 2,522 2,129 2,528 2,825 2,603 3,020
Cash & Equivalents
381 717 646 354 393 1,213 347 345 410 374 458
Accounts Receivable
603 592 668 733 745 597 829 919 1,013 949 1,119
Inventories, net
514 492 541 625 625 559 769 1,044 1,132 1,022 1,106
Other Current Assets
73 76 80 125 263 153 184 219 269 258 336
Plant, Property, & Equipment, net
485 473 493 554 549 527 617 636 891 819 855
Total Noncurrent Assets
4,557 4,699 5,368 6,272 7,270 7,308 9,152 9,267 11,308 11,210 12,192
Long-Term Investments
177 146 239 256 280 293 375 382 465 503 620
Goodwill
2,707 2,819 3,116 3,612 4,048 4,225 5,239 5,373 6,448 6,556 7,171
Intangible Assets
1,673 1,734 2,013 2,404 2,763 2,624 3,369 3,342 4,165 3,915 4,128
Other Noncurrent Operating Assets
- - - - 180 167 170 170 230 236 273
Total Liabilities & Shareholders' Equity
6,660 7,101 7,796 8,662 9,845 10,357 11,898 12,431 15,024 14,631 16,068
Total Liabilities
3,406 3,844 3,768 4,420 4,729 4,408 5,026 4,955 6,293 4,976 5,439
Total Current Liabilities
1,024 924 1,139 1,259 1,426 1,076 1,563 1,564 2,883 2,099 2,843
Short-Term Debt
385 279 308 359 497 132 315 226 1,418 654 1,209
Accounts Payable
365 370 437 400 377 360 470 497 517 523 618
Accrued Expenses
241 246 359 314 364 350 443 435 503 473 537
Current Deferred Revenue
- - 0.00 137 157 195 299 358 376 364 396
Current Deferred & Payable Income Tax Liabilities
33 30 35 49 30 39 36 48 70 84 83
Total Noncurrent Liabilities
2,382 2,920 2,630 3,162 3,303 3,332 3,463 3,390 3,411 2,877 2,596
Long-Term Debt
1,553 2,063 1,866 2,274 2,271 2,281 2,229 2,159 1,895 1,425 1,074
Noncurrent Deferred & Payable Income Tax Liabilities
624 622 513 528 536 533 720 694 837 831 789
Other Noncurrent Operating Liabilities
205 235 251 359 496 517 514 537 679 621 733
Total Equity & Noncontrolling Interests
3,255 3,257 4,028 4,242 5,115 5,949 6,872 7,477 8,730 9,655 10,629
Total Preferred & Common Equity
3,255 3,257 4,028 4,242 5,115 5,949 6,872 7,477 8,730 9,655 10,629
Total Common Equity
3,255 3,257 4,028 4,242 5,115 5,949 6,872 7,477 8,730 9,655 10,629
Common Stock
571 607 664 709 835 924 1,015 1,097 1,171 1,267 1,320
Retained Earnings
3,975 4,404 5,002 5,654 6,388 7,095 7,900 8,857 9,940 11,058 12,252
Treasury Stock
-885 -1,212 -1,209 -1,570 -1,574 -1,565 -1,573 -1,903 -1,897 -2,114 -2,544
Accumulated Other Comprehensive Income / (Loss)
-406 -542 -429 -551 -533 -504 -470 -575 -485 -556 -399

Quarterly Balance Sheets for AMETEK

This table presents AMETEK's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
12,840 13,093 15,024 14,865 14,796 14,768 14,631 14,877 15,267 16,182 16,310
Total Current Assets
2,900 3,119 2,825 2,776 2,767 2,734 2,603 2,761 3,052 3,062 3,138
Cash & Equivalents
606 842 410 374 397 396 374 399 620 439 481
Accounts Receivable
937 937 1,013 984 976 968 949 997 1,021 1,136 1,154
Inventories, net
1,108 1,088 1,132 1,127 1,102 1,085 1,022 1,070 1,111 1,153 1,143
Other Current Assets
249 252 269 291 293 285 258 296 301 333 359
Plant, Property, & Equipment, net
638 632 891 877 862 823 819 831 836 846 840
Total Noncurrent Assets
9,303 9,343 11,308 11,212 11,167 11,211 11,210 11,285 11,378 12,275 12,332
Long-Term Investments
402 415 465 473 483 499 503 509 528 576 637
Goodwill
5,450 5,479 6,448 6,439 6,454 6,550 6,556 6,631 6,724 7,185 7,266
Intangible Assets
3,279 3,284 4,165 4,081 4,013 3,951 3,915 3,917 3,880 4,246 4,165
Other Noncurrent Operating Assets
172 165 230 220 217 211 236 228 246 268 263
Total Liabilities & Shareholders' Equity
12,840 13,093 15,024 14,865 14,796 14,768 14,631 14,877 15,267 16,182 16,310
Total Liabilities
4,758 4,751 6,293 5,897 5,543 5,217 4,976 4,907 4,878 5,655 5,390
Total Current Liabilities
1,341 1,674 2,883 2,503 2,203 1,967 2,099 1,963 1,868 2,650 2,756
Short-Term Debt
5.40 304 1,418 1,055 828 571 654 472 408 1,038 1,115
Accounts Payable
488 487 517 517 510 512 523 534 549 582 619
Accrued Expenses
417 458 503 452 440 469 473 447 454 532 467
Current Deferred Revenue
383 363 376 392 378 351 364 387 380 416 464
Current Deferred & Payable Income Tax Liabilities
48 62 70 86 47 65 84 123 78 81 91
Total Noncurrent Liabilities
3,417 3,077 3,411 3,394 3,340 3,250 2,877 2,945 3,009 3,006 2,634
Long-Term Debt
2,186 1,856 1,895 1,878 1,823 1,765 1,425 1,459 1,534 1,426 1,063
Noncurrent Deferred & Payable Income Tax Liabilities
653 630 837 837 819 793 831 845 808 851 840
Other Noncurrent Operating Liabilities
578 591 679 680 698 692 621 641 667 728 732
Total Equity & Noncontrolling Interests
8,081 8,343 8,730 8,968 9,252 9,550 9,655 9,970 10,389 10,527 10,919
Total Preferred & Common Equity
8,081 8,343 8,730 8,968 9,252 9,550 9,655 9,970 10,389 10,527 10,919
Total Common Equity
8,081 8,343 8,730 8,968 9,252 9,550 9,655 9,970 10,389 10,527 10,919
Common Stock
1,127 1,151 1,171 1,189 1,213 1,231 1,267 1,258 1,279 1,294 1,317
Retained Earnings
9,372 9,655 9,940 10,187 10,460 10,735 11,058 11,338 11,625 11,925 12,574
Treasury Stock
-1,896 -1,896 -1,897 -1,897 -1,898 -1,959 -2,114 -2,108 -2,108 -2,259 -2,539
Accumulated Other Comprehensive Income / (Loss)
-522 -568 -485 -510 -522 -458 -556 -518 -406 -433 -432

Annual Metrics And Ratios for AMETEK

This table displays calculated financial ratios and metrics derived from AMETEK's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.19% -3.38% 11.98% 12.69% 6.45% -11.99% 22.17% 10.89% 7.26% 5.22% 6.63%
EBITDA Growth
2.37% -7.69% 11.46% 17.76% 9.68% 2.25% 12.08% 14.77% 10.62% 6.50% 6.72%
EBIT Growth
1.52% -12.33% 13.63% 19.58% 8.25% 0.88% 11.57% 15.98% 11.66% 5.11% 5.92%
NOPAT Growth
1.93% -12.12% 32.24% 9.60% 11.91% -12.59% 27.84% 14.98% 14.60% 5.59% 6.68%
Net Income Growth
1.09% -13.32% 33.06% 14.16% 10.72% 1.29% 13.48% 17.12% 13.25% 4.79% 7.56%
EPS Growth
3.38% -10.61% 34.25% 13.61% 12.28% 0.53% 12.73% 17.88% 13.17% 4.59% 7.93%
Operating Cash Flow Growth
-7.36% 12.53% 10.10% 11.07% 20.41% 14.95% -9.41% -0.96% 50.98% 5.39% -1.48%
Free Cash Flow Firm Growth
71.96% 6.97% -60.56% -152.83% 100.98% 118,988.55% -165.76% 200.16% -182.11% 379.09% -66.57%
Invested Capital Growth
4.81% 2.17% 12.29% 17.83% 15.12% -4.91% 26.78% 5.05% 22.28% -2.78% 8.99%
Revenue Q/Q Growth
-0.90% -0.39% 4.12% 2.72% 0.65% -2.28% 5.81% 2.02% 1.62% 0.44% 3.31%
EBITDA Q/Q Growth
-1.95% -1.97% 4.70% 4.85% 1.64% 0.42% 5.03% 2.95% 2.17% 1.37% 1.78%
EBIT Q/Q Growth
-2.66% -4.46% 6.29% 5.66% 1.04% 0.44% 5.13% 2.84% 2.40% 1.45% 1.65%
NOPAT Q/Q Growth
-1.50% -5.55% 24.18% -4.42% 1.56% -0.73% 6.19% 1.94% 3.18% 3.02% 1.04%
Net Income Q/Q Growth
-2.50% -5.14% 23.44% -3.36% 1.09% 0.03% 6.53% 2.24% 2.80% 3.33% 0.77%
EPS Q/Q Growth
-2.00% -4.37% 23.53% -3.47% 1.35% -0.26% 6.52% 2.45% 2.72% 3.31% 0.95%
Operating Cash Flow Q/Q Growth
-2.03% 6.76% 0.67% 4.91% 4.31% 3.53% -8.22% 9.86% 9.85% 0.51% 1.94%
Free Cash Flow Firm Q/Q Growth
7.05% 3.45% -16.39% -118.35% -99.63% 441.43% -26.83% -17.97% -172.61% 667.35% 4.20%
Invested Capital Q/Q Growth
-2.57% -3.52% 0.29% 11.12% 14.43% -0.88% 1.94% 4.10% 20.79% -1.22% -1.18%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.13% 32.67% 33.46% 34.25% 34.65% 34.00% 34.48% 34.88% 36.15% 35.68% 36.04%
EBITDA Margin
26.36% 25.18% 25.07% 26.20% 26.99% 31.36% 28.77% 29.77% 30.71% 31.08% 31.11%
Operating Margin
22.84% 20.60% 21.01% 22.20% 22.82% 22.64% 23.59% 24.40% 25.88% 25.64% 25.81%
EBIT Margin
22.60% 20.50% 20.81% 22.08% 22.45% 25.73% 23.50% 24.58% 25.59% 25.56% 25.40%
Profit (Net Income) Margin
14.87% 13.34% 15.85% 16.05% 16.70% 19.22% 17.85% 18.85% 19.91% 19.83% 20.00%
Tax Burden Percent
73.27% 73.89% 85.53% 78.76% 80.51% 80.61% 80.94% 81.16% 81.75% 82.82% 82.31%
Interest Burden Percent
89.78% 88.02% 89.04% 92.32% 92.36% 92.63% 93.83% 94.50% 95.15% 93.63% 95.68%
Effective Tax Rate
26.73% 26.11% 14.47% 21.24% 19.49% 19.39% 19.06% 18.84% 18.25% 17.18% 17.69%
Return on Invested Capital (ROIC)
14.69% 12.48% 15.38% 14.63% 14.07% 11.78% 13.62% 13.66% 13.75% 13.38% 13.86%
ROIC Less NNEP Spread (ROIC-NNEP)
8.89% 7.42% 8.77% 10.45% 9.86% 14.70% 8.55% 10.30% 9.72% 8.01% 6.20%
Return on Net Nonoperating Assets (RNNOA)
3.51% 3.25% 3.33% 4.19% 4.34% 3.99% 1.82% 2.50% 2.46% 1.59% 0.74%
Return on Equity (ROE)
18.20% 15.73% 18.71% 18.81% 18.41% 15.77% 15.44% 16.16% 16.21% 14.97% 14.59%
Cash Return on Invested Capital (CROIC)
10.00% 10.33% 3.80% -1.74% 0.01% 16.81% -10.00% 8.74% -6.30% 16.20% 5.26%
Operating Return on Assets (OROA)
13.73% 11.44% 12.01% 13.00% 12.52% 11.57% 11.71% 12.43% 12.30% 11.97% 12.25%
Return on Assets (ROA)
9.03% 7.44% 9.15% 9.45% 9.31% 8.64% 8.90% 9.53% 9.57% 9.28% 9.64%
Return on Common Equity (ROCE)
18.20% 15.73% 18.71% 18.81% 18.41% 15.77% 15.44% 16.16% 16.21% 14.97% 14.59%
Return on Equity Simple (ROE_SIMPLE)
18.15% 15.73% 16.92% 18.34% 16.84% 14.66% 14.41% 15.51% 15.04% 14.25% 0.00%
Net Operating Profit after Tax (NOPAT)
665 584 773 847 948 829 1,059 1,218 1,396 1,474 1,572
NOPAT Margin
16.74% 15.22% 17.97% 17.48% 18.38% 18.25% 19.10% 19.80% 21.16% 21.23% 21.24%
Net Nonoperating Expense Percent (NNEP)
5.80% 5.06% 6.61% 4.18% 4.21% -2.92% 5.07% 3.36% 4.03% 5.37% 7.65%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 12.35% 11.59% 12.56% 12.18%
Cost of Revenue to Revenue
65.87% 67.33% 66.54% 65.75% 65.35% 66.00% 65.52% 65.12% 63.86% 64.32% 63.96%
SG&A Expenses to Revenue
11.29% 12.07% 12.45% 12.05% 11.83% 11.36% 10.89% 10.48% 10.26% 10.04% 10.23%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
11.29% 12.07% 12.45% 12.05% 11.83% 11.36% 10.89% 10.48% 10.26% 10.04% 10.23%
Earnings before Interest and Taxes (EBIT)
898 787 895 1,070 1,158 1,168 1,304 1,512 1,688 1,775 1,880
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,048 967 1,078 1,269 1,392 1,424 1,596 1,831 2,026 2,157 2,302
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.70 3.29 3.98 3.57 4.32 4.57 4.87 4.24 4.33 4.32 4.45
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.03 2.79 3.73 3.13 4.29 5.99 6.03 5.15 5.73 6.01 6.39
Price to Earnings (P/E)
20.37 20.89 23.52 19.47 25.68 31.18 33.79 27.32 28.80 30.30 31.93
Dividend Yield
0.71% 0.78% 0.52% 0.86% 0.58% 0.61% 0.55% 0.64% 0.61% 0.62% 0.60%
Earnings Yield
4.91% 4.79% 4.25% 5.14% 3.89% 3.21% 2.96% 3.66% 3.47% 3.30% 3.13%
Enterprise Value to Invested Capital (EV/IC)
2.90 2.57 3.26 2.74 3.36 4.10 4.06 3.65 3.60 3.95 4.10
Enterprise Value to Revenue (EV/Rev)
3.38 3.17 4.03 3.54 4.69 6.19 6.36 5.42 6.10 6.18 6.55
Enterprise Value to EBITDA (EV/EBITDA)
12.81 12.59 16.06 13.53 17.39 19.74 22.11 18.20 19.87 19.88 21.05
Enterprise Value to EBIT (EV/EBIT)
14.94 15.47 19.35 16.05 20.91 24.06 27.06 22.05 23.85 24.17 25.79
Enterprise Value to NOPAT (EV/NOPAT)
20.17 20.84 22.40 20.27 25.54 33.92 33.30 27.37 28.84 29.11 30.83
Enterprise Value to Operating Cash Flow (EV/OCF)
19.95 16.09 20.78 18.55 21.73 21.94 30.40 29.00 23.20 23.46 26.90
Enterprise Value to Free Cash Flow (EV/FCFF)
29.64 25.15 90.68 0.00 24,387.54 23.77 0.00 42.80 0.00 24.04 81.25
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.60 0.72 0.54 0.62 0.54 0.41 0.37 0.32 0.38 0.22 0.21
Long-Term Debt to Equity
0.48 0.63 0.46 0.54 0.44 0.38 0.32 0.29 0.22 0.15 0.10
Financial Leverage
0.39 0.44 0.38 0.40 0.44 0.27 0.21 0.24 0.25 0.20 0.12
Leverage Ratio
2.01 2.11 2.05 1.99 1.98 1.83 1.74 1.70 1.69 1.61 1.51
Compound Leverage Factor
1.81 1.86 1.82 1.84 1.83 1.69 1.63 1.60 1.61 1.51 1.45
Debt to Total Capital
37.32% 41.83% 35.06% 38.30% 35.12% 28.86% 27.02% 24.19% 27.51% 17.72% 17.68%
Short-Term Debt to Total Capital
7.41% 4.98% 4.97% 5.22% 6.31% 1.58% 3.35% 2.29% 11.77% 5.58% 9.36%
Long-Term Debt to Total Capital
29.91% 36.85% 30.09% 33.08% 28.81% 27.28% 23.67% 21.89% 15.74% 12.15% 8.32%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
62.68% 58.17% 64.94% 61.70% 64.88% 71.14% 72.98% 75.82% 72.49% 82.28% 82.32%
Debt to EBITDA
1.85 2.42 2.02 2.07 1.99 1.70 1.59 1.30 1.64 0.96 0.99
Net Debt to EBITDA
1.32 1.53 1.20 1.59 1.51 0.64 1.14 0.90 1.20 0.56 0.52
Long-Term Debt to EBITDA
1.48 2.13 1.73 1.79 1.63 1.60 1.40 1.18 0.94 0.66 0.47
Debt to NOPAT
2.91 4.01 2.81 3.11 2.92 2.91 2.40 1.96 2.37 1.41 1.45
Net Debt to NOPAT
2.07 2.53 1.67 2.39 2.21 1.10 1.72 1.36 1.75 0.82 0.77
Long-Term Debt to NOPAT
2.34 3.53 2.41 2.68 2.40 2.75 2.10 1.77 1.36 0.97 0.68
Altman Z-Score
4.10 3.61 4.50 4.02 4.70 5.64 5.81 5.82 5.34 7.00 7.14
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.58 2.09 1.70 1.46 1.42 2.34 1.36 1.62 0.98 1.24 1.06
Quick Ratio
0.96 1.42 1.15 0.86 0.80 1.68 0.75 0.81 0.49 0.63 0.55
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
453 484 191 -101 0.99 1,182 -777 779 -639 1,784 597
Operating Cash Flow to CapEx
973.52% 1,196.01% 1,109.92% 1,127.64% 1,088.88% 1,726.41% 1,048.56% 826.86% 1,273.62% 1,439.19% 1,383.33%
Free Cash Flow to Firm to Interest Expense
4.93 5.13 1.95 -1.23 0.01 13.74 -9.67 9.36 -7.82 15.80 7.34
Operating Cash Flow to Interest Expense
7.33 8.03 8.50 11.26 12.60 14.88 14.44 13.82 21.22 16.19 22.17
Operating Cash Flow Less CapEx to Interest Expense
6.57 7.35 7.73 10.26 11.44 14.02 13.06 12.15 19.55 15.07 20.57
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.61 0.56 0.58 0.59 0.56 0.45 0.50 0.51 0.48 0.47 0.48
Accounts Receivable Turnover
6.69 6.42 6.82 6.92 6.98 6.76 7.78 7.04 6.83 7.08 7.16
Inventory Turnover
5.18 5.14 5.54 5.47 5.40 5.06 5.47 4.42 3.87 4.15 4.45
Fixed Asset Turnover
8.52 8.02 8.90 9.25 9.35 8.44 9.70 9.82 8.64 8.12 8.84
Accounts Payable Turnover
6.97 7.04 7.09 7.61 8.68 8.13 8.75 8.28 8.31 8.59 8.30
Days Sales Outstanding (DSO)
54.59 56.82 53.50 52.76 52.27 53.96 46.94 51.88 53.45 51.58 51.00
Days Inventory Outstanding (DIO)
70.43 71.05 65.86 66.74 67.64 72.09 66.71 82.63 94.30 88.05 82.05
Days Payable Outstanding (DPO)
52.39 51.87 51.46 47.93 42.06 44.92 41.72 44.08 43.92 42.51 44.00
Cash Conversion Cycle (CCC)
72.63 76.00 67.89 71.57 77.86 81.13 71.94 90.43 103.84 97.13 89.04
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,634 4,735 5,316 6,264 7,211 6,858 8,694 9,134 11,169 10,858 11,834
Invested Capital Turnover
0.88 0.82 0.86 0.84 0.77 0.65 0.71 0.69 0.65 0.63 0.65
Increase / (Decrease) in Invested Capital
213 100 582 948 947 -354 1,837 439 2,035 -311 976
Enterprise Value (EV)
13,416 12,178 17,315 17,169 24,213 28,107 35,275 33,331 40,257 42,898 48,468
Market Capitalization
12,037 10,700 16,026 15,147 22,117 27,199 33,452 31,674 37,818 41,696 47,263
Book Value per Share
$13.68 $14.07 $17.43 $18.28 $22.38 $25.86 $29.71 $32.56 $37.83 $41.74 $46.17
Tangible Book Value per Share
($4.73) ($5.60) ($4.77) ($7.64) ($7.41) ($3.91) ($7.50) ($5.39) ($8.16) ($3.53) ($2.91)
Total Capital
5,193 5,598 6,202 6,875 7,884 8,363 9,416 9,862 12,044 11,735 12,912
Total Debt
1,938 2,342 2,174 2,633 2,769 2,414 2,544 2,385 3,313 2,080 2,283
Total Long-Term Debt
1,553 2,063 1,866 2,274 2,271 2,281 2,229 2,159 1,895 1,425 1,074
Net Debt
1,380 1,478 1,289 2,023 2,096 908 1,822 1,657 2,439 1,203 1,205
Capital Expenditures (CapEx)
69 63 75 82 102 74 111 139 136 127 130
Debt-free, Cash-free Net Working Capital (DFCFNWC)
599 565 458 582 704 366 534 845 950 785 928
Debt-free Net Working Capital (DFNWC)
980 1,283 1,104 936 1,097 1,579 881 1,190 1,360 1,159 1,386
Net Working Capital (NWC)
595 1,004 796 577 600 1,447 565 964 -58 504 177
Net Nonoperating Expense (NNE)
74 72 91 69 87 -44 69 58 83 98 92
Net Nonoperating Obligations (NNO)
1,380 1,478 1,289 2,023 2,096 908 1,822 1,657 2,439 1,203 1,205
Total Depreciation and Amortization (D&A)
149 180 183 199 234 255 292 319 338 383 423
Debt-free, Cash-free Net Working Capital to Revenue
15.06% 14.72% 10.65% 12.02% 13.65% 8.06% 9.62% 13.73% 14.40% 11.31% 12.54%
Debt-free Net Working Capital to Revenue
24.65% 33.40% 25.68% 19.32% 21.27% 34.78% 15.88% 19.35% 20.62% 16.69% 18.73%
Net Working Capital to Revenue
14.97% 26.14% 18.51% 11.92% 11.63% 31.86% 10.19% 15.67% -0.88% 7.27% 2.39%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.46 $2.20 $2.96 $3.37 $3.78 $3.80 $4.29 $5.04 $5.70 $5.95 $6.42
Adjusted Weighted Average Basic Shares Outstanding
239.91M 232.59M 230.23M 230.82M 227.76M 229.44M 230.96M 230.21M 230.52M 231.26M 230.45M
Adjusted Diluted Earnings per Share
$2.45 $2.19 $2.94 $3.34 $3.75 $3.77 $4.25 $5.01 $5.67 $5.93 $6.40
Adjusted Weighted Average Diluted Shares Outstanding
241.59M 233.73M 231.85M 232.71M 229.40M 231.15M 232.81M 231.54M 231.51M 232.17M 231.26M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
235.54M 229.47M 231.33M 227.13M 229.12M 230.56M 231.70M 230.09M 231.01M 230.66M 228.98M
Normalized Net Operating Profit after Tax (NOPAT)
665 584 773 847 948 829 1,059 1,218 1,396 1,474 1,572
Normalized NOPAT Margin
16.74% 15.22% 17.97% 17.48% 18.38% 18.25% 19.10% 19.80% 21.16% 21.23% 21.24%
Pre Tax Income Margin
20.29% 18.05% 18.53% 20.38% 20.74% 23.84% 22.05% 23.23% 24.35% 23.94% 24.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.78 8.35 9.13 13.02 13.09 13.58 16.22 18.17 20.64 15.71 23.13
NOPAT to Interest Expense
7.25 6.20 7.88 10.31 10.71 9.63 13.18 14.64 17.06 13.05 19.35
EBIT Less CapEx to Interest Expense
9.03 7.68 8.36 12.02 11.93 12.71 14.84 16.50 18.97 14.58 21.53
NOPAT Less CapEx to Interest Expense
6.49 5.53 7.12 9.31 9.56 8.77 11.80 12.97 15.40 11.92 17.75
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
14.55% 16.26% 12.14% 16.57% 14.80% 18.92% 18.65% 17.44% 17.54% 18.81% 19.28%
Augmented Payout Ratio
88.24% 81.89% 13.15% 63.83% 16.19% 19.45% 20.13% 46.14% 18.13% 34.21% 48.60%

Quarterly Metrics And Ratios for AMETEK

This table displays calculated financial ratios and metrics derived from AMETEK's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 228,977,202.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 228,977,202.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.74
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.58% 6.47% 8.71% 5.39% 5.28% 1.77% -0.24% 2.49% 10.77% 13.44% 11.34%
EBITDA Growth
10.82% 8.77% 6.64% 9.99% 4.02% 5.49% 8.74% 3.74% 7.34% 7.17% 10.69%
EBIT Growth
11.38% 9.84% 4.10% 7.83% 2.80% 5.74% 8.79% 2.55% 5.97% 6.54% 13.39%
NOPAT Growth
15.81% 13.30% 4.16% 5.78% 0.42% 11.69% 8.30% 3.24% 11.80% 4.01% 13.22%
Net Income Growth
14.36% 11.65% 1.71% 4.15% -0.04% 12.95% 13.13% 6.13% 9.16% 2.93% 13.53%
EPS Growth
13.95% 11.28% 1.52% 3.57% 0.00% 12.84% 13.43% 6.90% 8.84% 3.59% 14.47%
Operating Cash Flow Growth
44.55% 40.42% 6.13% 13.78% 3.03% 1.73% 1.78% -5.86% -9.50% 6.23% 8.14%
Free Cash Flow Firm Growth
-269.20% -1,334.87% -952.89% -539.02% -1,139.77% 143.09% 128.60% 115.45% 58.16% -176.55% -232.11%
Invested Capital Growth
5.38% 22.28% 20.04% 18.99% 18.87% -2.78% -0.56% 1.44% 8.95% 8.99% 8.97%
Revenue Q/Q Growth
-1.41% 6.66% 0.31% -0.08% -1.51% 3.10% -1.68% 2.66% 6.44% 5.59% -3.50%
EBITDA Q/Q Growth
3.42% 3.76% -3.45% 6.16% -2.19% 5.22% -0.47% 1.28% 1.21% 5.05% 2.80%
EBIT Q/Q Growth
4.04% 2.12% -5.55% 7.45% -0.81% 5.04% -2.82% 1.28% 2.50% 5.61% 3.42%
NOPAT Q/Q Growth
5.28% 1.46% -7.03% 6.52% -0.06% 12.85% -9.85% 1.54% 8.23% 4.98% -1.87%
Net Income Q/Q Growth
4.97% 0.73% -9.31% 8.60% 0.76% 13.82% -9.17% 1.88% 3.64% 7.32% 0.19%
EPS Q/Q Growth
5.00% 0.68% -9.46% 8.21% 1.38% 13.61% -8.98% 1.97% 3.23% 8.13% 0.58%
Operating Cash Flow Q/Q Growth
41.05% 14.34% -24.12% -7.02% 27.72% 12.90% -24.08% -14.00% 22.77% 32.53% -22.72%
Free Cash Flow Firm Q/Q Growth
48.96% -1,396.30% 9.83% 7.21% 0.97% 152.01% -40.15% -49.89% -368.24% 4.84% -3.29%
Invested Capital Q/Q Growth
-0.20% 20.79% -1.02% -0.28% -0.29% -1.22% 1.24% 1.73% 7.09% -1.18% 1.22%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.09% 35.53% 34.07% 35.99% 36.04% 36.60% 36.09% 35.76% 36.25% 36.05% 37.21%
EBITDA Margin
31.65% 30.79% 29.64% 31.49% 31.27% 31.92% 32.31% 31.87% 30.30% 30.15% 32.12%
Operating Margin
27.00% 25.71% 24.03% 25.80% 26.10% 26.62% 26.26% 25.96% 25.80% 25.29% 26.70%
EBIT Margin
26.61% 25.48% 23.99% 25.80% 25.98% 26.47% 26.17% 25.82% 24.86% 24.86% 26.65%
Profit (Net Income) Margin
20.97% 19.81% 17.91% 19.46% 19.91% 21.98% 20.31% 20.16% 19.62% 19.95% 20.71%
Tax Burden Percent
82.32% 82.23% 81.54% 80.98% 81.23% 87.15% 81.01% 81.05% 82.91% 84.10% 81.01%
Interest Burden Percent
95.74% 94.53% 91.54% 93.17% 94.34% 95.28% 95.81% 96.33% 95.21% 95.39% 95.93%
Effective Tax Rate
17.68% 17.77% 18.46% 19.02% 18.77% 12.85% 18.99% 18.95% 17.09% 15.90% 18.99%
Return on Invested Capital (ROIC)
16.01% 13.74% 13.03% 14.05% 14.48% 14.62% 13.39% 13.23% 13.35% 13.88% 14.31%
ROIC Less NNEP Spread (ROIC-NNEP)
14.42% 12.61% 11.37% 12.38% 12.61% 13.44% 12.31% 12.00% 11.03% 11.68% 12.60%
Return on Net Nonoperating Assets (RNNOA)
2.37% 3.19% 2.41% 2.11% 1.65% 2.66% 2.02% 1.57% 1.59% 1.39% 1.26%
Return on Equity (ROE)
18.38% 16.93% 15.43% 16.16% 16.13% 17.29% 15.41% 14.80% 14.94% 15.26% 15.56%
Cash Return on Invested Capital (CROIC)
9.77% -6.30% -4.30% -3.25% -3.11% 16.20% 14.19% 12.20% 4.99% 5.26% 5.53%
Operating Return on Assets (OROA)
13.75% 12.25% 11.76% 12.74% 12.89% 12.39% 12.21% 11.99% 11.51% 11.99% 12.98%
Return on Assets (ROA)
10.84% 9.52% 8.78% 9.61% 9.88% 10.29% 9.47% 9.36% 9.09% 9.62% 10.09%
Return on Common Equity (ROCE)
18.38% 16.93% 15.43% 16.16% 16.13% 17.29% 15.41% 14.80% 14.94% 15.26% 15.56%
Return on Equity Simple (ROE_SIMPLE)
15.31% 0.00% 14.70% 14.39% 13.94% 0.00% 14.21% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
361 366 340 362 362 409 368 374 405 425 417
NOPAT Margin
22.22% 21.14% 19.60% 20.89% 21.20% 23.20% 21.27% 21.04% 21.39% 21.27% 21.63%
Net Nonoperating Expense Percent (NNEP)
1.59% 1.13% 1.65% 1.67% 1.87% 1.18% 1.07% 1.23% 2.32% 2.20% 1.71%
Return On Investment Capital (ROIC_SIMPLE)
- 3.04% - - - 3.48% 3.10% 3.03% 3.12% 3.29% 3.19%
Cost of Revenue to Revenue
62.91% 64.47% 65.93% 64.01% 63.96% 63.40% 63.91% 64.24% 63.75% 63.95% 62.79%
SG&A Expenses to Revenue
10.09% 9.82% 10.04% 10.20% 9.95% 9.98% 9.83% 9.80% 10.45% 10.75% 10.51%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.09% 9.82% 10.04% 10.20% 9.95% 9.98% 9.83% 9.80% 10.45% 10.75% 10.51%
Earnings before Interest and Taxes (EBIT)
432 441 417 448 444 466 453 459 470 497 514
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
514 533 515 546 534 562 560 567 574 603 619
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.06 4.33 4.70 4.17 4.16 4.32 3.98 4.02 4.12 4.45 4.50
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.22 5.73 6.26 5.65 5.75 6.01 5.72 5.99 6.06 6.39 6.46
Price to Earnings (P/E)
26.52 28.80 31.97 28.97 29.85 30.30 28.02 29.06 29.56 31.93 32.13
Dividend Yield
0.66% 0.61% 0.56% 0.64% 0.63% 0.62% 0.67% 0.65% 0.64% 0.60% 0.59%
Earnings Yield
3.77% 3.47% 3.13% 3.45% 3.35% 3.30% 3.57% 3.44% 3.38% 3.13% 3.11%
Enterprise Value to Invested Capital (EV/IC)
3.76 3.60 4.00 3.66 3.75 3.95 3.71 3.81 3.75 4.10 4.19
Enterprise Value to Revenue (EV/Rev)
5.36 6.10 6.57 5.91 5.96 6.18 5.87 6.10 6.26 6.55 6.60
Enterprise Value to EBITDA (EV/EBITDA)
17.54 19.87 21.49 19.15 19.36 19.88 18.49 19.15 19.83 21.05 21.23
Enterprise Value to EBIT (EV/EBIT)
21.09 23.85 25.95 23.23 23.55 24.17 22.49 23.36 24.27 25.79 25.84
Enterprise Value to NOPAT (EV/NOPAT)
25.71 28.84 31.38 28.24 28.80 29.11 27.12 28.13 28.83 30.83 30.93
Enterprise Value to Operating Cash Flow (EV/OCF)
22.01 23.20 25.15 22.36 22.64 23.46 22.18 23.47 25.38 26.90 27.31
Enterprise Value to Free Cash Flow (EV/FCFF)
39.49 0.00 0.00 0.00 0.00 24.04 26.04 31.42 78.37 81.25 78.96
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.26 0.38 0.33 0.29 0.24 0.22 0.19 0.19 0.23 0.21 0.20
Long-Term Debt to Equity
0.22 0.22 0.21 0.20 0.18 0.15 0.15 0.15 0.14 0.10 0.10
Financial Leverage
0.16 0.25 0.21 0.17 0.13 0.20 0.16 0.13 0.14 0.12 0.10
Leverage Ratio
1.62 1.69 1.64 1.59 1.56 1.61 1.57 1.53 1.54 1.51 1.49
Compound Leverage Factor
1.55 1.60 1.50 1.49 1.47 1.54 1.50 1.47 1.47 1.44 1.43
Debt to Total Capital
20.57% 27.51% 24.65% 22.27% 19.66% 17.72% 16.23% 15.75% 18.97% 17.68% 16.63%
Short-Term Debt to Total Capital
2.90% 11.77% 8.87% 6.96% 4.80% 5.58% 3.96% 3.31% 7.99% 9.36% 8.51%
Long-Term Debt to Total Capital
17.67% 15.74% 15.78% 15.32% 14.85% 12.15% 12.26% 12.44% 10.98% 8.32% 8.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
79.43% 72.49% 75.35% 77.73% 80.34% 82.28% 83.77% 84.25% 81.03% 82.32% 83.37%
Debt to EBITDA
1.09 1.64 1.43 1.26 1.10 0.96 0.88 0.87 1.09 0.99 0.92
Net Debt to EBITDA
0.46 1.20 1.01 0.84 0.68 0.56 0.46 0.36 0.64 0.52 0.45
Long-Term Debt to EBITDA
0.94 0.94 0.91 0.87 0.83 0.66 0.66 0.69 0.63 0.47 0.45
Debt to NOPAT
1.60 2.37 2.08 1.86 1.63 1.41 1.29 1.28 1.58 1.45 1.34
Net Debt to NOPAT
0.67 1.75 1.48 1.24 1.01 0.82 0.68 0.52 0.93 0.77 0.65
Long-Term Debt to NOPAT
1.37 1.36 1.33 1.28 1.23 0.97 0.97 1.01 0.92 0.68 0.66
Altman Z-Score
6.05 5.06 5.82 5.77 6.22 6.71 6.55 6.85 6.21 6.86 7.14
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.86 0.98 1.11 1.26 1.39 1.24 1.41 1.63 1.16 1.06 1.14
Quick Ratio
1.06 0.49 0.54 0.62 0.69 0.63 0.71 0.88 0.59 0.55 0.59
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-112 -1,669 -1,505 -1,397 -1,383 719 431 216 -579 -551 -569
Operating Cash Flow to CapEx
1,649.25% 904.97% 1,483.53% 1,781.07% 1,853.63% 1,063.35% 1,809.98% 1,226.86% 2,108.09% 1,025.08% 1,772.88%
Free Cash Flow to Firm to Interest Expense
-6.07 -69.21 -42.70 -45.66 -55.06 32.70 22.67 12.80 -25.70 -24.06 -27.20
Operating Cash Flow to Interest Expense
25.72 22.42 11.64 12.47 19.40 25.00 21.98 21.30 19.58 25.52 21.59
Operating Cash Flow Less CapEx to Interest Expense
24.16 19.94 10.85 11.77 18.35 22.65 20.77 19.57 18.65 23.03 20.38
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.48 0.49 0.49 0.50 0.47 0.47 0.46 0.46 0.48 0.49
Accounts Receivable Turnover
7.16 6.83 7.15 7.13 7.25 7.08 7.01 6.99 6.81 7.16 7.07
Inventory Turnover
3.94 3.87 3.86 3.98 4.11 4.15 4.03 4.03 4.09 4.45 4.37
Fixed Asset Turnover
10.58 8.64 8.89 9.11 9.50 8.12 8.12 8.22 8.59 8.84 9.09
Accounts Payable Turnover
8.23 8.31 8.31 8.80 8.94 8.59 8.42 8.41 8.36 8.30 8.39
Days Sales Outstanding (DSO)
50.98 53.45 51.08 51.16 50.31 51.58 52.10 52.22 53.60 51.00 51.66
Days Inventory Outstanding (DIO)
92.68 94.30 94.49 91.82 88.81 88.05 90.56 90.55 89.31 82.05 83.48
Days Payable Outstanding (DPO)
44.34 43.92 43.93 41.48 40.81 42.51 43.36 43.38 43.65 44.00 43.52
Cash Conversion Cycle (CCC)
99.31 103.84 101.65 101.50 98.31 97.13 99.31 99.39 99.26 89.04 91.62
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
9,247 11,169 11,055 11,024 10,992 10,858 10,993 11,183 11,975 11,834 11,979
Invested Capital Turnover
0.72 0.65 0.66 0.67 0.68 0.63 0.63 0.63 0.62 0.65 0.66
Increase / (Decrease) in Invested Capital
472 2,035 1,845 1,759 1,745 -311 -62 158 984 976 986
Enterprise Value (EV)
34,775 40,257 44,232 40,360 41,199 42,898 40,728 42,574 44,868 48,468 50,143
Market Capitalization
33,871 37,818 42,145 38,588 39,757 41,696 39,706 41,780 43,419 47,263 49,084
Book Value per Share
$36.16 $37.83 $38.81 $39.97 $41.25 $41.74 $43.22 $45.00 $45.58 $46.17 $47.69
Tangible Book Value per Share
($1.82) ($8.16) ($6.71) ($5.25) ($4.11) ($3.53) ($2.51) ($0.93) ($3.91) ($2.91) ($2.24)
Total Capital
10,503 12,044 11,901 11,904 11,887 11,735 11,901 12,331 12,991 12,912 13,097
Total Debt
2,161 3,313 2,933 2,651 2,337 2,080 1,931 1,942 2,464 2,283 2,178
Total Long-Term Debt
1,856 1,895 1,878 1,823 1,765 1,425 1,459 1,534 1,426 1,074 1,063
Net Debt
904 2,439 2,087 1,772 1,442 1,203 1,023 794 1,448 1,205 1,059
Capital Expenditures (CapEx)
29 60 28 21 26 52 23 29 21 57 25
Debt-free, Cash-free Net Working Capital (DFCFNWC)
908 950 955 996 942 785 871 971 1,011 928 1,015
Debt-free Net Working Capital (DFNWC)
1,749 1,360 1,328 1,392 1,338 1,159 1,270 1,591 1,450 1,386 1,496
Net Working Capital (NWC)
1,445 -58 273 564 767 504 798 1,183 412 177 381
Net Nonoperating Expense (NNE)
20 23 29 25 22 21 17 16 34 26 18
Net Nonoperating Obligations (NNO)
904 2,439 2,087 1,772 1,442 1,203 1,023 794 1,448 1,205 1,059
Total Depreciation and Amortization (D&A)
82 92 98 99 90 96 106 108 103 106 105
Debt-free, Cash-free Net Working Capital to Revenue
13.98% 14.40% 14.17% 14.59% 13.63% 11.31% 12.55% 13.92% 14.11% 12.54% 13.36%
Debt-free Net Working Capital to Revenue
26.95% 20.62% 19.72% 20.40% 19.36% 16.69% 18.30% 22.79% 20.24% 18.73% 19.69%
Net Working Capital to Revenue
22.26% -0.88% 4.05% 8.27% 11.10% 7.27% 11.51% 16.95% 5.75% 2.39% 5.02%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.48 $1.48 $1.35 $1.46 $1.47 $1.67 $1.52 $1.55 $1.61 $1.74 $1.74
Adjusted Weighted Average Basic Shares Outstanding
230.69M 230.52M 231.10M 231.44M 231.34M 231.26M 230.67M 230.82M 230.73M 230.45M 228.90M
Adjusted Diluted Earnings per Share
$1.47 $1.48 $1.34 $1.45 $1.47 $1.67 $1.52 $1.55 $1.60 $1.73 $1.74
Adjusted Weighted Average Diluted Shares Outstanding
231.75M 231.51M 232.04M 232.30M 232.22M 232.17M 231.54M 231.47M 231.67M 231.26M 229.84M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
230.80M 231.01M 231.47M 231.54M 231.31M 230.66M 230.88M 230.95M 230.20M 228.98M 229.20M
Normalized Net Operating Profit after Tax (NOPAT)
361 366 340 362 362 409 368 374 405 425 417
Normalized NOPAT Margin
22.22% 21.14% 19.60% 20.89% 21.20% 23.20% 21.27% 21.04% 21.39% 21.27% 21.63%
Pre Tax Income Margin
25.48% 24.09% 21.96% 24.04% 24.51% 25.22% 25.07% 24.87% 23.67% 23.72% 25.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
23.49 18.29 11.82 14.63 17.68 21.20 23.86 27.23 20.90 21.71 24.58
NOPAT to Interest Expense
19.62 15.17 9.65 11.85 14.42 18.58 19.40 22.19 17.99 18.57 19.95
EBIT Less CapEx to Interest Expense
21.93 15.81 11.03 13.93 16.63 18.85 22.65 25.49 19.97 19.22 23.36
NOPAT Less CapEx to Interest Expense
18.06 12.70 8.87 11.15 13.37 16.23 18.18 20.46 17.06 16.08 18.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.48% 17.54% 18.01% 18.37% 18.90% 18.81% 18.74% 18.94% 19.00% 19.28% 19.09%
Augmented Payout Ratio
18.10% 18.13% 18.63% 19.03% 24.10% 34.21% 34.49% 34.42% 39.95% 48.60% 48.15%

Financials Breakdown Chart

Key Financial Trends

Here are key takeaways from AMETEK, Inc. (NYSE: AME) quarterly results over the last four years, focusing on revenue, profitability, cash flow, and the balance sheet. The bullets highlight trends that may matter to retail investors.

  • Revenue trend: AMETEK’s 2025 Q4 revenue reached about $1,998,448,000, up from roughly $1,761,600,000 in 2024 Q4, signaling sustained top‑line growth through the year.
  • Earnings per share: Diluted EPS for 2025 Q4 was $1.73, up from $1.67 in 2024 Q4, showing margin‑plus earnings progress alongside higher revenue.
  • Cash flow from operations: Net cash from continuing operating activities in 2025 Q4 was $584,264,000, underscoring strong cash generation to support investment and returns.
  • Profitability stability: Gross margin sits in the mid‑30s percent (about 36%), indicating solid profitability consistency across the period.
  • Balance sheet strength: Cash & equivalents around $439.2 million (as of 2025 Q3) and total equity near $10.56 billion reflect strong liquidity and a solid capital base.
  • Shareholder returns: The company maintains a per‑share dividend of $0.31, supporting ongoing returns to shareholders.
  • Acquisition activity: A sizable acquisition in 2025 Q3 (about $829.1 million) indicates growth expansion, though it introduces integration risk and one‑offs to watch.
  • Leverage level: Long‑term debt levels run roughly in the $1.4–1.5 billion range over 2025, suggesting moderate leverage given the scale of acquisitions and cash flow.
  • Capital expenditure: Quarterly capex remains moderate (PPE purchases around $56.0 million in Q4 2025), consistent with ongoing investment without heavy near‑term capex pressure.
  • Margin compression risk: Net income margin in 2025 Q4 (~19.9%) dipped versus 2024 Q4 (~22%), suggesting some margin pressure to monitor amid ongoing costs and one‑offs.
05/06/26 12:52 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About AMETEK's Financials

When does AMETEK's fiscal year end?

According to the most recent income statement we have on file, AMETEK's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has AMETEK's net income changed over the last 10 years?

AMETEK's net income appears to be on an upward trend, with a most recent value of $1.48 billion in 2025, rising from $590.86 million in 2015. The previous period was $1.38 billion in 2024. See AMETEK's forecast for analyst expectations on what’s next for the company.

What is AMETEK's operating income?
AMETEK's total operating income in 2025 was $1.91 billion, based on the following breakdown:
  • Total Gross Profit: $2.67 billion
  • Total Operating Expenses: $757.12 million
How has AMETEK's revenue changed over the last 10 years?

Over the last 10 years, AMETEK's total revenue changed from $3.97 billion in 2015 to $7.40 billion in 2025, a change of 86.2%.

How much debt does AMETEK have?

AMETEK's total liabilities were at $5.44 billion at the end of 2025, a 9.3% increase from 2024, and a 59.7% increase since 2015.

How much cash does AMETEK have?

In the past 10 years, AMETEK's cash and equivalents has ranged from $345.39 million in 2022 to $1.21 billion in 2020, and is currently $457.95 million as of their latest financial filing in 2025.

How has AMETEK's book value per share changed over the last 10 years?

Over the last 10 years, AMETEK's book value per share changed from 13.68 in 2015 to 46.17 in 2025, a change of 237.5%.



Financial statements for NYSE:AME last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners